XML 55 R36.htm IDEA: XBRL DOCUMENT v3.20.2
NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Property, Plant and Equipment [Line Items]        
Impairment of intangible assets   $ 0    
Amortization of Intangible Assets $ 754,102 1,499,613    
Inventory Valuation Reserves $ 5,965,139 $ 5,965,139   $ 0
Council License Agreement [Member]        
Property, Plant and Equipment [Line Items]        
Annual royalty rate reduction of initial rate during the six-month period from commercial sale of a generic equivalent   50.00%    
Annual royalty rate reduction of initial rate after six-month period from commercial sale of a generic equivalent   20.00%    
Maximum costs and expenses for post approval   $ 20,000,000    
Council License Agreement Step 1        
Property, Plant and Equipment [Line Items]        
Royalty (percent)   5.00%    
Council License Agreement Step 2        
Property, Plant and Equipment [Line Items]        
Royalty (percent)   10.00%    
Council License Agreement Step 3        
Property, Plant and Equipment [Line Items]        
Royalty (percent)   15.00%    
Vitamins and IMVEXXY [Member]        
Property, Plant and Equipment [Line Items]        
Shelf life of prescription products following product expiration   24 months    
BIJUVA and ANNOVERA [Member]        
Property, Plant and Equipment [Line Items]        
Shelf life of prescription products following product expiration   18 months    
ANNOVERA [Member] | Council License Agreement [Member]        
Property, Plant and Equipment [Line Items]        
Milestone payment upon FDA Approval   $ 20,000,000    
Milestone payments (payment after release of first commercial batch)   20,000,000    
License rights acquired   20,000,000    
Milestone payments upon specified levels of cumulative net sales   40,000,000    
Specified level one of cumulative net sales for milestone payments   200,000,000    
Specified level two of cumulative net sales for milestone payments   400,000,000    
Specified level three of cumulative net sales for milestone payments   $ 1,000,000,000    
Minimum [Member]        
Property, Plant and Equipment [Line Items]        
Return period of unsalable prescription products   6 months    
Minimum [Member] | Council License Agreement Step 2        
Property, Plant and Equipment [Line Items]        
Net sales amount per step-based royalty   $ 50,000,000    
Minimum [Member] | Council License Agreement Step 3        
Property, Plant and Equipment [Line Items]        
Net sales amount per step-based royalty   $ 150,000,000    
Maximum [Member]        
Property, Plant and Equipment [Line Items]        
Return period of unsalable prescription products   12 months    
Maximum [Member] | Council License Agreement Step 1        
Property, Plant and Equipment [Line Items]        
Net sales amount per step-based royalty   $ 50,000,000    
Maximum [Member] | Council License Agreement Step 2        
Property, Plant and Equipment [Line Items]        
Net sales amount per step-based royalty   $ 150,000,000    
Performance Shares [Member]        
Property, Plant and Equipment [Line Items]        
Common stock, shares, issued (in dollars per share) $ 0.001 $ 0.001    
Restricted Stock [Member]        
Property, Plant and Equipment [Line Items]        
Common stock, shares, issued (in dollars per share) $ 0.001 $ 0.001    
Trademarks and Trade Names [Member]        
Property, Plant and Equipment [Line Items]        
Impairment of intangible assets     $ 78,864  
Fair Value, Recurring [Member]        
Property, Plant and Equipment [Line Items]        
Assets or liabilities valued at fair value $ 0 $ 0 $ 0